Does RUXOLITINIB Cause Fibrosis? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Fibrosis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
47
Reports of Fibrosis with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
5
Deaths
10
Hospitalizations
How Dangerous Is Fibrosis From RUXOLITINIB?
Of the 47 reports, 5 (10.6%) resulted in death, 10 (21.3%) required hospitalization.
Is Fibrosis Listed in the Official Label?
Yes, Fibrosis is listed as a known adverse reaction in the official FDA drug label for RUXOLITINIB.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Fibrosis?
METHOTREXATE (122)
ADALIMUMAB (118)
PREDNISONE (85)
RITUXIMAB (84)
MYCOPHENOLATE MOFETIL (70)
DICLOFENAC (67)
METFORMIN (52)
HYDROXYCHLOROQUINE (51)
TACROLIMUS (51)
ETANERCEPT (50)
Which RUXOLITINIB Alternatives Have Lower Fibrosis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE